Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market - Prokidney, Inversago, Palatin Technologies, Lexicon, Daiichi Sankyo, CSL Behring
November 07, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market - Prokidney, Inversago,...
European Patent Office to Grant ZyVersa Therapeutics’ Patent Application for Cholesterol Transport Mediator™ VAR 200 for Use in Patients with Diabetic Nephropathy/Diabetic Kidney Disease
June 06, 2023 09:07 ET
|
ZyVersa Therapeutics
Cholesterol Transport Mediator™ VAR 200 is in development to reduce renal cholesterol and lipid accumulation that damages the kidneys' filtration system in patients with glomerular diseases, including...
Diabetic Nephropathy Market Size Expected to Reach USD 3.34 Billion by 2028, at a 4.3% CAGR
March 09, 2023 07:39 ET
|
Fortune Business Insights
Pune, India, March 09, 2023 (GLOBE NEWSWIRE) -- The global diabetic nephropathy market size was valued at USD 2.38 billion in 2020. The market is estimated to rise from USD 2.49 billion in 2021 to...
Diabetic Nephropathy Market Size Worth USD 3.43 Billion by 2030 at 6.20% CAGR – Report by Market Research Future (MRFR)
February 22, 2023 09:00 ET
|
Market Research Future
New York, USA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Diabetic Nephropathy Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), The Diabetic Nephropathy...
Diabetic Nephropathy Market Is Expected to Reach $3.3 Billion by 2031, Says AMR
July 13, 2022 08:28 ET
|
Allied Market Research
Portland, OR, July 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global diabetic nephropathy market was estimated at $1.9 billion in 2021 and is...
Diabetic Nephropathy Market Size [2022-2028] worth USD 3.34 Billion | exhibiting a CAGR of 4.3%
March 22, 2022 09:05 ET
|
Fortune Business Insights
Pune, India, March 22, 2022 (GLOBE NEWSWIRE) -- The global diabetic nephropathy market size was valued at USD 2.38 billion in 2020. The market is estimated to rise from USD 2.49 billion in 2021 to...
Diabetic Nephropathy Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Analysis, Forecast Report
July 20, 2021 05:56 ET
|
Fortune Business Insights
Pune, India, July 20, 2021 (GLOBE NEWSWIRE) -- The increasing prevalence of diabetes around the world is expected to spur opportunities for the market during the forecast period, states Fortune...
Cyclerion Updates Corporate Progress
April 10, 2020 07:00 ET
|
Cyclerion Therapeutics, Inc.
– Closed enrollment for olinciguat Phase 2 STRONG SCD study for sickle cell disease; topline data readout expected Q3 2020 – – Closed enrollment for IW-6463 translational pharmacology...
Cyclerion announces IW-6463 phase 1 healthy volunteer study results that support further development for neurodegenerative diseases
January 13, 2020 07:00 ET
|
Cyclerion Therapeutics, Inc.
– Results in 110 subjects demonstrate favorable safety, CNS pharmacokinetics, and evidence of target engagement – – Study underway in elderly subjects to further assess cerebral blood flow and...
Cyclerion to Present at the J.P. Morgan Healthcare Conference
December 23, 2019 07:00 ET
|
Cyclerion Therapeutics, Inc.
– Management to review the Company's sGC clinical pipeline programs: praliciguat for diabetic nephropathy, olinciguat for sickle cell disease, and IW-6463 for neurodegenerative diseases – CAMBRIDGE,...